• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

Chemical Profile of (4-fluoro-2-pyridyl)methanamine (CAS No. 859166-87-3)

(4-fluoro-2-pyridyl)methanamine, with the CAS number 859166-87-3, is a fluorinated pyridine derivative that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, characterized by its unique structural and electronic properties, exhibits promising potential in various applications, particularly in the development of novel therapeutic agents.

The molecular structure of (4-fluoro-2-pyridyl)methanamine consists of a pyridine ring substituted with a fluoro group at the 4-position and an amine group at the 2-position, linked by a methylene bridge. This configuration imparts distinct chemical reactivity and binding capabilities, making it a valuable intermediate in synthetic chemistry. The presence of the fluoro group enhances the metabolic stability and bioavailability of drug candidates, which is a critical factor in pharmaceutical design.

In recent years, there has been growing interest in fluorinated pyridines due to their role as key pharmacophores in medicinal chemistry. The fluorine atom's ability to influence electronic properties, lipophilicity, and metabolic pathways has made these compounds attractive for drug development. (4-fluoro-2-pyridyl)methanamine is no exception and has been explored in several research studies for its potential applications.

One of the most notable areas where (4-fluoro-2-pyridyl)methanamine has been investigated is in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways and are often targeted in cancer therapy. The pyridine moiety in (4-fluoro-2-pyridyl)methanamine can be readily functionalized to develop selective kinase inhibitors. For instance, studies have demonstrated its utility in creating inhibitors targeting tyrosine kinases, which are overexpressed in many cancer types. These inhibitors have shown promise in preclinical models, highlighting the compound's potential as a lead molecule.

The fluorine atom at the 4-position of the pyridine ring contributes to the compound's binding affinity by enhancing interactions with biological targets. This feature is particularly valuable in drug design, as it can improve both potency and selectivity. Additionally, the amine group provides a site for further derivatization, allowing chemists to fine-tune the properties of the compound for specific applications.

Another area where (4-fluoro-2-pyridyl)methanamine has been explored is in the development of antiviral agents. The structural features of this compound make it a suitable candidate for inhibiting viral proteases and polymerases. Recent research has shown that fluorinated pyridines can effectively disrupt viral replication cycles by interfering with key enzymatic steps. This makes (4-fluoro-2-pyridyl)methanamine a promising candidate for further investigation in antiviral drug discovery.

The synthesis of (4-fluoro-2-pyridyl)methanamine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic substitution reactions on halogenated pyridines followed by functional group transformations to introduce the amine and methylene groups. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to explore its applications on a larger scale.

In conclusion, (4-fluoro-2-pyridyl)methanamine (CAS No. 859166-87-3) is a versatile fluorinated pyridine derivative with significant potential in pharmaceutical research. Its unique structural features make it an attractive intermediate for developing kinase inhibitors, antiviral agents, and other therapeutic compounds. As research continues to uncover new applications for this compound, its importance in medicinal chemistry is likely to grow further.

• 766-16-5(4-Fluoro-2-methylpyridine)
• 1060802-37-0((5-fluoropyridin-2-yl)methyl(methyl)amine)
• 1257535-13-9((4-Fluoropyridin-2-yl)methanamine dihydrochloride)
• 1780747-77-4((6-Fluoroisoquinolin-3-yl)methanamine)
• 1241725-81-4((4-Fluoropyridin-2-yl)methanamine hydrochloride)
• 312904-51-1((3-Fluoropyridin-2-yl)methanamine)
• 1060809-42-8((4-fluoropyridin-2-yl)methyl(methyl)amine)
• 561297-96-9((5-fluoro-2-pyridyl)methanamine)
• 1228788-32-6((5-Fluoropyridin-2-yl)methanamine hydrochloride)
• 859164-78-6(5-fluoro-2-Pyridinemethanamine hydrochloride)